Study to Compare Exposure of TA Following Administration of FX006 or TAcs in Patients With OA of the Shoulder or Hip
Clinical trial NCT03382262 · COMPLETED
Trial details
- NCT number
- NCT03382262
- Sponsor
- Pacira Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-18
- Primary completion
- 2018-10-09
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.